About RAD
Radiopharm Theranostics Limited (RAD) operates as a clinical stage radiotherapeutics organisation developing a platform of radiopharmaceutical products for diagnostic and therapeutic use in areas of unmet medical need. The development pipeline consists of platform technologies that include peptides, small molecules, and monoclonal antibodies for cancer applications.
Find out what a historical investment in Radiopharm Theranostics would be worth today using our RAD stock calculator.
Market Capitalisation
$23.55M
Price-earnings ratio
-0.28
Dividend yield
-
High today
$0.01
Low today
$0.00
Open price
$0.01
52-week high
$0.04
52-week low
$0.00
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RAD
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in RAD on Stake
- Buy RAD from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
RAD related stocks